Press release
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial Infection to Drive Market
The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.
Obtain Report Details @ https://www.transparencymarketresearch.com/us-bacterial-conjunctivitis-drugs-market.html
Rising Prevalence of MDROs Creates Serious Challenge for Market’s Growth
Apart from this, the rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.
Although the market is facing a number of restraints at present, it may experience a little relief in future if the product development partnerships (PDPs) models for business are implemented by participants. As various research and development procedures incur a high amount, exerting substantial pressure on pharma companies, strategic alliances with small biotech research organizations will prove to be beneficial for both the parties.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=12323
Market Encroachment by Generic Variations to Limit Demand for Topical Fluoroquinolones
Fluoroquinolones, macrolides, and aminoglycosides are the major classes of drugs used for the treatment of bacterial conjunctivitis. The demand for topical fluoroquinolones is the highest among all classes of bacterial conjunctivitis drugs in the U.S. However, the segment is projected to be hindered severely in the coming years, owing to the forthcoming patent expirations of bestselling drugs of this class, such as Vigamox, Moxeza, and Zymaxid by the end of 2016.
The market’s opportunity will also be hurt significantly over the next few years due to the encroachment by generic variations of these drugs and decline from US$361.9 mn in 2013 to US$286.4 mn by 2024.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12323
Imminent Patent Expiries to Hurt Leading Players Severely
Valeant Pharmaceuticals Int. Inc., Santen Pharmaceutical Co. Ltd., Pfizer Inc., Perrigo Com. Plc., Novartis AG, Merck & Co. Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Akorn Inc., and Actavis Plc. are leading the market for bacterial conjunctivitis drugs in the U.S. The imminent patent expiries is likely to hurt the business of these players significantly in the near future. However, the rising prevalence of bacterial infection in eyes and the increasing susceptibility to infection among individuals of various age groups may provide rewarding opportunities to participants over the next few years.
Players are recommended to focus on developing herbal medicines for the treatment of bacterial conjunctivitis, as the consumer preference is shifting from pharmacological medicines to herbal treatment regimens.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial Infection to Drive Market here
News-ID: 1228958 • Views: 499
More Releases from Transparency Market Research
Rising Demand for Drug Discovery Outsourcing Market: Latest Innovation & Upcomin …
The global Drug Discovery Outsourcing market is estimated to attain a valuation of US$ 7.5 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 7.8% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders…
Advancements in Portable Fire Extinguisher Market: An Overview of Latest Develop …
The global Portable Fire Extinguisher market is estimated to attain a valuation of US$ 12.5 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 5.4% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders…
Acrylic Syntan Market to grow at a CAGR of 6.7 by the end of 2031- TMR Study
The global Acrylic Syntan market is estimated to attain a valuation of US$ 364.2 Mn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.7% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Global Last Mile Delivery Transportation Market Poised for 4.8% CAGR Growth, Tar …
The latest research study released by Transparency Market Research on "𝗟𝗮𝘀𝘁 𝗠𝗶𝗹𝗲 𝗗𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗧𝗿𝗮𝗻𝘀𝗽𝗼𝗿𝘁𝗮𝘁𝗶𝗼𝗻 𝗠𝗮𝗿𝗸𝗲𝘁 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝘁𝗼 𝟮𝟬𝟮𝟯-𝟮𝟬𝟯𝟭″ research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Last Mile Delivery Transportation industry,…
More Releases for MDROs
A new formula against Multidrug-Resistant Organisms (MDROs)
Our DECONTAMAN PRE product range for skin and hand decontamination including hygienic, full body washing offers fast and complete efficacy as well as excellent skin compatibility. In order to meet the high standards and requirements of our customers and also their future needs, Dr. Schumacher GmbH has released updated and optimized formulations for the whole range.
Infections in the medical sector caused by multidrug-resistant organisms (MDROs) pose a serious problem…
Bacterial Conjunctivitis Drugs Market is set to garner staggering revenues by 2 …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market is likely to reduce to US$439.8 mn by 2024
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
U.S. Bacterial Conjunctivitis Drugs Market 2024: Overview, Opportunities, In-Dep …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market: Rising Prevalence of MDROs Creates Seriou …
Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
